Irinotecan Accord 20 mg/ml inf. sol. (conc.) i.v. vial Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan accord 20 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - irinotecan hydrochloride trihydrate 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors

Irinotecan Accord 20 mg/ml inf. sol. (conc.) i.v. vial Belgium - Inggeris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan accord 20 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - irinotecan hydrochloride trihydrate 20 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors

IRINOTECAN HYDROCHLORIDE Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

irinotecan hydrochloride

hospira uk limited - irinotecan hydrochloride trihydrate - concentrate for soln for inf - 20 mg/ml - irinotecan

Hospira irinotecan hydrochloride trihydrate Trihydrate for injection 500 mg/25 mL vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

hospira irinotecan hydrochloride trihydrate trihydrate for injection 500 mg/25 ml vial

hospira australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: lactic acid; sorbitol; water for injections; sodium hydroxide; hydrochloric acid - irinotecan hydrochloride trihydrate is indicated as: - a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum; - a single agent for the treatment of patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following 5-fluorouracil-based therapy.

Hospira irinotecan hydrochloride trihydrate Trihydrate for Injection 100 mg/5 mL vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

hospira irinotecan hydrochloride trihydrate trihydrate for injection 100 mg/5 ml vial

hospira australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: lactic acid; sorbitol; water for injections; sodium hydroxide; hydrochloric acid - irinotecan hydrochloride trihydrate is indicated as: - a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum; - a single agent for the treatment of patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following 5-fluorouracil-based therapy.

Irinotecan Hydrochloride Concentrate for Soln for Inf 20mg/ml (5ml vial) Malta - Inggeris - Medicines Authority

irinotecan hydrochloride concentrate for soln for inf 20mg/ml (5ml vial)

accord healthcare limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Irinotecan Hydrochloride Concentrate for Soln for Inf 20mg/ml (15ml vial) Malta - Inggeris - Medicines Authority

irinotecan hydrochloride concentrate for soln for inf 20mg/ml (15ml vial)

accord healthcare limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Irinotecan Hydrochloride Concentrate for Soln for Inf 20mg/ml (25ml vial) Malta - Inggeris - Medicines Authority

irinotecan hydrochloride concentrate for soln for inf 20mg/ml (25ml vial)

accord healthcare limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Irinotecan Hydrochloride Concentrate for Soln for Inf 20mg/ml (2ml vial) Malta - Inggeris - Medicines Authority

irinotecan hydrochloride concentrate for soln for inf 20mg/ml (2ml vial)

accord healthcare limited - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

irinotecan accord irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

accord healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 100 mg - injection, concentrated - excipient ingredients: hydrochloric acid; lactic acid; sodium hydroxide; water for injections; sorbitol - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.